Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease

Publisher： John Wiley & Sons Inc

E-ISSN： 1875-9114|38|1|51-57

ISSN： 0277-0008

Source： PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol.38, Iss.1, 2018-01, pp. : 51-57

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytomegalovirus‐negative kidney transplant recipients are at an increased risk for malignancy after kidney transplantation

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 30, Iss. 9, 2016-09 ,pp. : 980-985

John Wiley & Sons Inc

Access to resources Recommend Favorite

Solid‐type RCC originating from native kidneys in renal transplant recipients should be monitored cautiously

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 813-819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteinuria in pediatric renal transplant recipients

By  

PEDIATRIC TRANSPLANTATION, Vol. 22, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Outcome of Single Pediatric Deceased Donor Renal Transplantation to Adult Kidney Transplant Recipients

By  

Urologia Internationalis, Vol. 92, Iss. 3, 2013-11 ,pp. : 323-327

Karger

Access to resources Recommend Favorite

Chronic Kidney Disease Management: Comparison between Renal Transplant Recipients and Nontransplant Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 107, Iss. 1, 2007-07 ,pp. : c7-c13

Karger

Access to resources Recommend Favorite